| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Century Therapeutics Inc. Common Stock (NASDAQ: IPSC)
IPSC Technical Analysis
5
| As on 8th Jan 2026 IPSC STOCK Price closed @ 1.77 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 0.66 & Strong Buy for SHORT-TERM with Stoploss of 1.03 we also expect STOCK to react on Following IMPORTANT LEVELS. |
IPSCSTOCK Price
| Open | 1.60 | Change | Price | % |
| High | 1.88 | 1 Day | 0.47 | 36.15 |
| Low | 1.55 | 1 Week | 0.77 | 77.00 |
| Close | 1.77 | 1 Month | 1.25 | 240.38 |
| Volume | 19433470 | 1 Year | 0.05 | 2.91 |
| 52 Week High 1.77 | 52 Week Low 0.39 | ||||
NASDAQ USA Most Active Stocks
| LPTX | 2.05 | 365.91% |
| AMRS | 0.14 | 100.00% |
| WBA | 11.98 | 0.50% |
| NVDA | 185.04 | -2.15% |
| OCG | 0.02 | 0.00% |
| ONDS | 14.01 | 15.02% |
| LMDX | 0.02 | 0.00% |
| YGMZ | 0.02 | -66.67% |
| SXTC | 1.25 | -37.50% |
| AKTS | 0.04 | 0.00% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| IPSC Daily Charts |
IPSC Intraday Charts |
Whats New @ Bazaartrend |
IPSC Free Analysis |
|
|
IPSC Important Levels Intraday
| RESISTANCE | 2.41 |
| RESISTANCE | 2.20 |
| RESISTANCE | 2.08 |
| RESISTANCE | 1.95 |
| SUPPORT | 1.59 |
| SUPPORT | 1.46 |
| SUPPORT | 1.34 |
| SUPPORT | 1.13 |
IPSC Forecast January 2026
| 4th UP Forecast | 2.93 |
| 3rd UP Forecast | 2.56 |
| 2nd UP Forecast | 2.33 |
| 1st UP Forecast | 2.1 |
| 1st DOWN Forecast | 1.44 |
| 2nd DOWN Forecast | 1.21 |
| 3rd DOWN Forecast | 0.98 |
| 4th DOWN Forecast | 0.61 |
IPSC Weekly Forecast
| 4th UP Forecast | 2.95 |
| 3rd UP Forecast | 2.57 |
| 2nd UP Forecast | 2.34 |
| 1st UP Forecast | 2.10 |
| 1st DOWN Forecast | 1.44 |
| 2nd DOWN Forecast | 1.20 |
| 3rd DOWN Forecast | 0.97 |
| 4th DOWN Forecast | 0.59 |
IPSC Forecast2026
| 4th UP Forecast | 4.74 |
| 3rd UP Forecast | 3.79 |
| 2nd UP Forecast | 3.2 |
| 1st UP Forecast | 2.61 |
| 1st DOWN Forecast | 0.93 |
| 2nd DOWN Forecast | 0.34 |
| 3rd DOWN Forecast | -0.25 |
| 4th DOWN Forecast | -1.2 |
Century Therapeutics Inc. Common Stock ( NASDAQ USA Symbol : IPSC )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
IPSC Business Profile
Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 for relapsed, refractory B-cell lymphoma. It is also developing CNTY-103, a CAR-iNK candidate targeting CD133 + EGFR for recurrent glioblastoma; CNTY-102, a CAR-iT or CAR-iNK candidate targeting CD19 + CD79b for relapsed, refractory B-cell lymphoma and other B-cell malignancies; and CNTY-104, a CAR-iT or CAR-iNK multi-specific candidate for acute myeloid leukemia. Century Therapeutics, Inc. has a research collaboration with Outpace Bio, Inc. for CAR engineering. The company was founded in 2018 and is headquartered in Philadelphia, Pennsylvania. Address: 3675 Market Street, Philadelphia, PA, United States, 19104
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service